Named to Institutional Investor’s 2021 All-Japan Executive Team as a top-scoring chief executive, Christophe Weber shares insight into Takeda’s innovation strategy.
Christophe Weber, named by Insider as one of 10 leaders transforming healthcare in Asia, reflects on Takeda’s transformation to a global, R&D-driven biopharmaceutical company.
In life, there are great opportunities as well as great challenges and risks. With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.
In the final installment of this interview series, Christophe Weber talks about the challenges of globalization with his message for the Japanese business community.
Christophe Weber on Takeda’s corporate governance system and the importance of being open and transparent to build trust.
Christophe Weber talks about how confidentiality was maintained during Shire negotiations and the challenges of large-scale integration.
President and CEO Christophe Weber explains how Takeda is developing “Global Talent” with the ability to perform on an international business stage.
Takeda was named Pharma Company of the Year at the 2019 Scrip Awards. The award winner is chosen by Scrip’s senior editorial team to honor outstanding achievements and strategic advancements over the past year.
Despite technological advances, the delivery of high-quality health care remains a human-centered activity. Takeda is supporting NGO Seed Global Health to use the power of people to tackle the health challenges of sub-Saharan Africa.
CEO Christophe Weber speaks openly to Eurobiz Japan on the ups and downs of Takeda's `total transformation`, his strategic approach to R&D and of the exciting promise of what's to come.